Education
About Us
Working with TipRanks
Follow Us
RenovoRx (RNXT)
NASDAQ:RNXT
Total Valuation
RenovoRx has a market cap or net worth of $46.45M. The enterprise value is ―.
Market Cap$46.45M
Enterprise Value―
Share Statistics
RenovoRx has 36,572,230 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding36,572,230
Owned by Insiders3.32%
Owned by Institutions22.15%
Financial Efficiency
RenovoRx’s return on equity (ROE) is 3.41 and return on invested capital (ROIC) is -3916.15%.
Return on Equity (ROE)3.41
Return on Assets (ROA)-6.98
Return on Invested Capital (ROIC)-3916.15%
Return on Capital Employed (ROCE)-39.16
Revenue Per Employee0.00
Profits Per Employee-1.02M
Employee Count10
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of RenovoRx is -2.30. RenovoRx’s PEG ratio is -0.50.
PE Ratio-2.30
PS Ratio0.00
PB Ratio3.21
Price to Fair Value-7.86
Price to FCF-3.70
Price to Operating Cash Flow-2.59
PEG Ratio-0.50
Income Statement
In the last 12 months, RenovoRx had revenue of 0.00 and earned -10.23M in profits. Earnings per share was -0.99.
Revenue0.00
Gross Profit0.00
Operating Income-11.40M
Pretax Income-10.23M
Net Income-10.23M
EBITDA-11.39M
Earnings Per Share (EPS)-0.99
Cash Flow
In the last 12 months, operating cash flow was -8.75M and capital expenditures 0.00, giving a free cash flow of -8.75M billion.
Operating Cash Flow-8.75M
Free Cash Flow-8.75M
Free Cash Flow per Share-0.24
Dividends & Yields
RenovoRx pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.37
52-Week Price Change14.04%
50-Day Moving Average1.21
200-Day Moving Average1.14
Relative Strength Index (RSI)49.25
Average Volume (3m)188.90K
Important Dates
RenovoRx upcoming earnings date is Aug 13, 2025, After Close (Confirmed).
Last Earnings DateMay 15, 2025
Next Earnings DateAug 13, 2025
Ex-Dividend Date―
Financial Position
RenovoRx as a current ratio of 1.25, with Debt / Equity ratio of 0.00%
Current Ratio1.25
Quick Ratio1.25
Debt to Market Cap0.00
Net Debt to EBITDA0.10
Interest Coverage Ratio-105.52
Taxes
In the past 12 months, RenovoRx has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
RenovoRx EV to EBITDA ratio is -1.97, with an EV/FCF ratio of -2.18.
EV to Sales0.00
EV to EBITDA-1.97
EV to Free Cash Flow-2.18
EV to Operating Cash Flow-2.18
Balance Sheet
RenovoRx has $9.56M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$9.56M billion.
Cash & Marketable Securities$9.56M
Total Debt$0.00
Net Cash-$9.56M
Net Cash Per Share-$0.26
Tangible Book Value Per Share-$0.29
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for RenovoRx is $5.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$5.50
Price Target Upside323.08% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast―
EPS Growth Forecast61.43%